325 related articles for article (PubMed ID: 22801499)
1. HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria.
Shui JW; Larange A; Kim G; Vela JL; Zahner S; Cheroutre H; Kronenberg M
Nature; 2012 Aug; 488(7410):222-5. PubMed ID: 22801499
[TBL] [Abstract][Full Text] [Related]
2. TNF Superfamily Networks: bidirectional and interference pathways of the herpesvirus entry mediator (TNFSF14).
Ware CF; Sedý JR
Curr Opin Immunol; 2011 Oct; 23(5):627-31. PubMed ID: 21920726
[TBL] [Abstract][Full Text] [Related]
3. The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation.
Steinberg MW; Cheung TC; Ware CF
Immunol Rev; 2011 Nov; 244(1):169-87. PubMed ID: 22017438
[TBL] [Abstract][Full Text] [Related]
4. LIGHT-HVEM Signaling in Innate Lymphoid Cell Subsets Protects Against Enteric Bacterial Infection.
Seo GY; Shui JW; Takahashi D; Song C; Wang Q; Kim K; Mikulski Z; Chandra S; Giles DA; Zahner S; Kim PH; Cheroutre H; Colonna M; Kronenberg M
Cell Host Microbe; 2018 Aug; 24(2):249-260.e4. PubMed ID: 30092201
[TBL] [Abstract][Full Text] [Related]
5. Unconventional ligand activation of herpesvirus entry mediator signals cell survival.
Cheung TC; Steinberg MW; Oborne LM; Macauley MG; Fukuyama S; Sanjo H; D'Souza C; Norris PS; Pfeffer K; Murphy KM; Kronenberg M; Spear PG; Ware CF
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6244-9. PubMed ID: 19332782
[TBL] [Abstract][Full Text] [Related]
6. The CD160, BTLA, LIGHT/HVEM pathway: a bidirectional switch regulating T-cell activation.
Cai G; Freeman GJ
Immunol Rev; 2009 May; 229(1):244-58. PubMed ID: 19426226
[TBL] [Abstract][Full Text] [Related]
7. CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells.
Šedý JR; Bjordahl RL; Bekiaris V; Macauley MG; Ware BC; Norris PS; Lurain NS; Benedict CA; Ware CF
J Immunol; 2013 Jul; 191(2):828-36. PubMed ID: 23761635
[TBL] [Abstract][Full Text] [Related]
8. CD160 isoforms and regulation of CD4 and CD8 T-cell responses.
El-Far M; Pellerin C; Pilote L; Fortin JF; Lessard IA; Peretz Y; Wardrop E; Salois P; Bethell RC; Cordingley MG; Kukolj G
J Transl Med; 2014 Sep; 12():217. PubMed ID: 25179432
[TBL] [Abstract][Full Text] [Related]
9. Activation of intestinal epithelial Stat3 orchestrates tissue defense during gastrointestinal infection.
Wittkopf N; Pickert G; Billmeier U; Mahapatro M; Wirtz S; Martini E; Leppkes M; Neurath MF; Becker C
PLoS One; 2015; 10(3):e0118401. PubMed ID: 25799189
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis for herpesvirus entry mediator recognition by the human immune inhibitory receptor CD160 and its relationship to the cosignaling molecules BTLA and LIGHT.
Kojima R; Kajikawa M; Shiroishi M; Kuroki K; Maenaka K
J Mol Biol; 2011 Nov; 413(4):762-72. PubMed ID: 21959263
[TBL] [Abstract][Full Text] [Related]
11. A herpesvirus entry mediator mutein with selective agonist action for the inhibitory receptor B and T lymphocyte attenuator.
Šedý JR; Balmert MO; Ware BC; Smith W; Nemčovičova I; Norris PS; Miller BR; Aivazian D; Ware CF
J Biol Chem; 2017 Dec; 292(51):21060-21070. PubMed ID: 29061848
[TBL] [Abstract][Full Text] [Related]
12. Cutting Edge: the BTLA-HVEM regulatory pathway interferes with protective immunity to intestinal Helminth infection.
Breloer M; Hartmann W; Blankenhaus B; Eschbach ML; Pfeffer K; Jacobs T
J Immunol; 2015 Feb; 194(4):1413-6. PubMed ID: 25595777
[TBL] [Abstract][Full Text] [Related]
13. HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160.
Liu W; Chou TF; Garrett-Thomson SC; Seo GY; Fedorov E; Ramagopal UA; Bonanno JB; Wang Q; Kim K; Garforth SJ; Kakugawa K; Cheroutre H; Kronenberg M; Almo SC
J Exp Med; 2021 Dec; 218(12):. PubMed ID: 34709351
[TBL] [Abstract][Full Text] [Related]
14. HVEM: An unusual TNF receptor family member important for mucosal innate immune responses to microbes.
Shui JW; Kronenberg M
Gut Microbes; 2013; 4(2):146-51. PubMed ID: 23333859
[TBL] [Abstract][Full Text] [Related]
15. Citrobacter rodentium: infection, inflammation and the microbiota.
Collins JW; Keeney KM; Crepin VF; Rathinam VA; Fitzgerald KA; Finlay BB; Frankel G
Nat Rev Microbiol; 2014 Sep; 12(9):612-23. PubMed ID: 25088150
[TBL] [Abstract][Full Text] [Related]
16. CD160 Stimulates CD8
Tan CL; Peluso MJ; Drijvers JM; Mera CM; Grande SM; Brown KE; Godec J; Freeman GJ; Sharpe AH
Immunohorizons; 2018 Aug; 2(7):238-250. PubMed ID: 31022694
[TBL] [Abstract][Full Text] [Related]
17. Structural Basis of CD160:HVEM Recognition.
Liu W; Garrett SC; Fedorov EV; Ramagopal UA; Garforth SJ; Bonanno JB; Almo SC
Structure; 2019 Aug; 27(8):1286-1295.e4. PubMed ID: 31230945
[TBL] [Abstract][Full Text] [Related]
18. Tpl2 Promotes Innate Cell Recruitment and Effector T Cell Differentiation To Limit Citrobacter rodentium Burden and Dissemination.
Acuff NV; Li X; Latha K; Nagy T; Watford WT
Infect Immun; 2017 Oct; 85(10):. PubMed ID: 28760932
[TBL] [Abstract][Full Text] [Related]
19. T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment.
Cheung TC; Oborne LM; Steinberg MW; Macauley MG; Fukuyama S; Sanjo H; D'Souza C; Norris PS; Pfeffer K; Murphy KM; Kronenberg M; Spear PG; Ware CF
J Immunol; 2009 Dec; 183(11):7286-96. PubMed ID: 19915044
[TBL] [Abstract][Full Text] [Related]
20. Citrobacter rodentium-induced colitis: A robust model to study mucosal immune responses in the gut.
Koroleva EP; Halperin S; Gubernatorova EO; Macho-Fernandez E; Spencer CM; Tumanov AV
J Immunol Methods; 2015 Jun; 421():61-72. PubMed ID: 25702536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
